Skip to content

Author

Muhindo Edgar

We have 1 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

Nanotechnology-Enabled Reprogramming of the Tumor Microenvironment: Targeting Cancer-Associated Fibroblasts and Immune Suppression

This review critically examines recent advances in nanotechnology-enabled targeting of CAFs and immune suppression within the TME, and concludes that nanotechnology-driven TME modulation represents a promising paradigm shift toward more durable and effective cancer therapies.

Muhindo Edgar · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.